Overview
ProAssurance Q3 net income falls 91.2% yr/yr to $1.4 mln
Consolidated net investment income rises 8.5%, reflecting higher book yields
Company continues premium rate adjustments in medical liability and workers' comp markets
Outlook
ProAssurance anticipates closing its merger with The Doctors Company by June 30, 2026
Result Drivers
PREMIUM RATE ADJUSTMENTS - Co continues to adjust premium rates in medical liability and workers' comp markets to align with challenging conditions
RENEWAL PREMIUM INCREASES - Specialty P&C segment saw 8% renewal premium increases, contributing to cumulative premium change of over 80% since 2018
INVESTMENT INCOME RISE - Consolidated net investment income increased 8.5%, reflecting higher average book yields
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Gross Premiums
$290.44 mln
Q3 Net Income
$1.44 mln
Q3 Adjusted Operating Income
$7.89 mln
Q3 Operating Expenses
$81.41 mln
Q3 Pretax Profit
$4.36 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the property & casualty insurance peer group is "buy."
Wall Street's median 12-month price target for ProAssurance Corp is $25.00, about 4.3% above its November 3 closing price of $23.93
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 25 three months ago
Press Release: ID:nBwbwpKwsa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)